MME and acute lymphoblastic leukemia: To identify novel markers for flow cytometric MRD assessment, Coustan-Smith et al. [62] evaluated gene expression of lymphoblasts from 270 BCP-ALL patients and CD19+CD10+ BCPs originating from four healthy donors by microarray analysis.